RecruitingNCT04592003

French Colorectal ESD Cohort in Experts Centers


Sponsor

University Hospital, Limoges

Enrollment

1,200 participants

Start Date

Jan 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Initially developed in Japan for the treatment of endemic superficial gastric cancers, endoscopic submucosal dissection (ESD) allows resection of pre-neoplastic and neoplastic lesions of the digestive tract into a single fragment. It allows a perfect pathological analysis, and decreases the rate of recurrence of the adenoma to less than 2%. However, this procedure, which is technically more challenging, is also more risky (perforation rate at 4% vs. 1% for WF-EMR) and longer. Submucosal dissection is also more expensive in terms of equipment, but this difference can be offset by the cost of the high number of iterative colonoscopies required in patients who have had endoscopic resection by WF-EMR. Scientific debate is agitating the Western world1,2 and Japanese experts do not perform WF-EMR anymore, whereas no comparative prospective study has compared these two procedures. A lot of centers in France performed colorectal ESD even for benign lesions and nationwide data about safety and efficiency is required to confirm the place of ESD for treatment of large superficial colorectal lesions. The aim of this French multicenter cohort is to analyze the results of colorectal submucosal dissection on a large scale.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This French registry study follows all patients who undergo a specialized endoscopic procedure called colorectal ESD (endoscopic submucosal dissection) — a minimally invasive technique used to remove large, flat, or complex polyps and very early colorectal cancers from the colon lining without the need for open surgery. It collects detailed data across multiple expert centers to evaluate safety, success rates, and recovery outcomes in real-world practice. **You may be eligible if...** - You are scheduled for colorectal ESD at one of the participating expert hospitals in France - You are undergoing ESD as part of your standard clinical care - You have been informed about the data collection and do not object to inclusion **You may NOT be eligible if...** - You specifically object to being included after reading the information notice provided Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREEndoscopic submucosal dissection

Endoscopic submucosal dissection


Locations(25)

CHU d'Amiens

Amiens, France

Clinique de l'Anjou

Angers, France

CHU de Besançon

Besançon, France

CHU de Bordeaux

Bordeaux, France

CHRU de Brest

Brest, France

CHU de Dijon

Dijon, France

CHU de Limoges

Limoges, France

Hopital Edouard Herriot

Lyon, France

Hôpital Jean Mermoz

Lyon, France

Hôpital Européen

Marseille, France

CHU de Montpellier

Montpellier, France

CHU de Nancy

Nancy, France

Clinique Jules Vernes

Nantes, France

CHU de Nantes

Nantes, France

CHU de Nice

Nice, France

CHU de Nîmes

Nîmes, France

Hôpital St Antoine

Paris, France

Hôpital Cochin - APHP

Paris, France

Hôpital St Joseph

Paris, France

Hôpital Européen Georges Pompidou-APHP

Paris, France

CHU de Rennes

Rennes, France

CHU de Rouen

Rouen, France

Clinique Santé Atlantique

Saint-Herblain, France

CHU de Strasbourg

Strasbourg, France

CHU de Toulouse

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04592003


Related Trials